AtriCure EPS
The Earnings per Share (EPS) of AtriCure (ATRC) as of Oct 9, 2026 is -0.23 USD. In the previous year, Earnings per Share (EPS) was -0.95 USD — a change of -75.31% (higher).
Get this data via API
Financial Data API
EPS
-0.23USD
YoY
-75.31%
Last updated:
The AtriCure EPS history
3 Years
10 Years
25 Years
Max
| YEAR | EPS | YoY |
|---|---|---|
| est | 1.05USD | +43.84% |
| est | 0.73USD | +4.78% |
| est | 0.70USD | +66.42% |
| est | 0.42USD | +291.49% |
| est | 0.11USD | -145.65% |
| -0.23USD | -75.31% | |
| -0.95USD | +44.80% | |
| -0.66USD | -35.25% | |
| -1.01USD | -191.39% | |
| 1.11USD | -201.47% | |
| -1.09USD | +18.43% | |
| -0.92USD | +59.05% | |
| -0.58USD | -29.64% | |
| -0.82USD | -21.46% | |
| -1.05USD | +18.04% | |
| -0.89USD | +47.59% | |
| -0.60USD | +9.14% | |
| -0.55USD | +19.54% | |
| -0.46USD | +35.43% | |
| -0.34USD | +38.32% | |
| -0.25USD | -77.61% | |
| -1.10USD | +54.66% | |
| -0.71USD | -10.58% | |
| -0.80USD | -28.70% | |
| -1.12USD | — |
AtriCure Stock analysis
Frequently Asked Questions about AtriCure stock
Earnings per Share (EPS) of AtriCure is -0.23 USD in 2025.
Earnings per Share (EPS) of AtriCure changed from -0.95 USD to -0.23 USD, representing a -75.31% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Earnings per Share (EPS) AtriCure since 2006 – with annual values, charts, and detailed analysis.
Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.
EPS = Net Income / Shares Outstanding
Income Statement — AtriCure
All Key Metrics — AtriCure
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth